Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy
出版年份 2019 全文链接
标题
Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy
作者
关键词
-
出版物
JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-02-12
DOI
10.1002/jcph.1388
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
- (2018) Craig M McDonald et al. LANCET
- Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
- (2018) Eric P. Hoffman et al. STEROIDS
- Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis
- (2018) Rohit T. Rao et al. CHRONOBIOLOGY INTERNATIONAL
- Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit
- (2018) Sen Chandra Sreetama et al. MOLECULAR THERAPY
- Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
- (2018) Laurie S. Conklin et al. PHARMACOLOGICAL RESEARCH
- VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis
- (2016) Jesse M. Damsker et al. INFLAMMATION RESEARCH
- A novel dissociative steroid VBP15 reduces MUC5AC gene expression in airway epithelial cells but lacks the GRE mediated transcriptional properties of dexamethasone
- (2016) Lindsay M. Garvin et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumor
- (2016) Elizabeth Wells et al. Oncotarget
- Gastrointestinal Dysfunction in Patients with Duchenne Muscular Dystrophy
- (2016) Christian M. Lo Cascio et al. PLoS One
- Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study
- (2015) Luca Bello et al. NEUROLOGY
- VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis
- (2014) Blythe C. Dillingham et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy
- (2014) Sherry Dadgar et al. JOURNAL OF CELL BIOLOGY
- Inhaled corticosteroids in children: effects on bone mineral density and growth
- (2014) Anne L Fuhlbrigge et al. Lancet Respiratory Medicine
- VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid
- (2013) Erica K.M. Reeves et al. BIOORGANIC & MEDICINAL CHEMISTRY
- VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
- (2013) Christopher R. Heier et al. EMBO Molecular Medicine
- Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
- (2013) Rebecca J. Fairclough et al. NATURE REVIEWS GENETICS
- VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice
- (2013) Jesse M. Damsker et al. PLoS One
- Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy
- (2011) D. M. Escolar et al. NEUROLOGY
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
- (2009) Katharine Bushby et al. LANCET NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started